UBXN2A suppresses the Rictor-mTORC2 signaling pathway, an established tumorigenic pathway in human colorectal cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
https://www.nature.com/articles/s41388-023-02686-7.pdf
Reference85 articles.
1. Roulin D, Cerantola Y, Dormond-Meuwly A, Demartines N, Dormond O. Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo. Mol Cancer. 2010;9:57.
2. Wong CK, Lambert AW, Ozturk S, Papageorgis P, Lopez D, Shen N, et al. Targeting RICTOR sensitizes SMAD4-negative colon cancer to irinotecan. Mol Cancer Res. 2020;18:414–423.
3. Ponnurangam S, Standing D, Rangarajan P, Subramaniam D. Tandutinib inhibits the Akt/mTOR signaling pathway to inhibit colon cancer growth. Mol Cancer Ther. 2013;12:598–609.
4. Shiratori H, Kawai K, Okada M, Nozawa H, Hata K, Tanaka T, et al. Metastatic role of mTOR signaling activation by chemoradiotherapy in advanced rectal cancer. Cancer Sci. 2020;111:1291–1302.
5. Jhanwar-Uniyal M, Wainwright JV, Mohan AL, Tobias ME, Murali R, Gandhi CD, et al. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship. Adv Biol Regul. 2019;72:51–62.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. mTORC2: A neglected player in aging regulation;Journal of Cellular Physiology;2024-07-10
2. RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition;Molecular Cancer;2024-05-16
3. Proteomic Profiling of Recurrent Colorectal Cancer Reveals RICTOR with Cancer-Promoting Role by Downregulating Mitochondrial Oxidative Phosphorylation;J BIOL REG HOMEOS AG;2024
4. Role of Post-Translational Modifications in Colorectal Cancer Metastasis;Cancers;2024-02-03
5. Unmasking the tumourigenic role of SIN1/MAPKAP1 in the mTOR complex 2;Clinical and Translational Medicine;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3